Cite

HARVARD Citation

    Mae, Y. et al. (2021). Administration route governs the complication: A case report of anaphylaxis due to intravenous erythropoiesis‐stimulating agent. Nephrology. 26 (6), p. 561. [Online]. 
  
Back to record